An employee handles one kilogram gold bullions at the YLG Bullion International Co. headquarters in Bangkok, Thailand, on Friday, Dec. 22, 2023.President Donald Trump said Monday that gold will not face tariffs.Gold futures closed at a record high Friday on reports that the precious metal would face duties. U.S. Customs and Border Protection reportedly said gold bars were not excluded from Trump's reciprocal tariffs. The White House on Friday said it would issue an executive order that clarifies "misinforma ...

💥BREAKING:🇺🇸 TRUMP SAYS GOLD WILL NOT NOT BE TARIFFED. https://t.co/POEJf1ZK0M ...

Trade Relations - Brazilian government is promoting a tariff relief plan [1] - The plan is happening amid discussions with the US Treasury [1] - The goal is to ease trade tensions between Brazil and the US [1]

US Consumers Will Bear the Brunt of Tariff Costs, Goldman Says https://t.co/4liSClfxPD ...

Summary of Conference Call on China Healthcare Sector Industry Overview - The conference call focused on the **China Healthcare** sector, particularly the pharmaceutical industry, amidst concerns regarding potential tariffs from the US on pharmaceutical products and services [1][67]. Key Points and Arguments 1. **Tariff Concerns**: The US announced a ~100% tariff on semiconductor chips, which has negatively impacted market sentiment regarding upcoming pharmaceutical tariffs [2][8]. 2. **Low Likelihood of Tariffs on BD Deal Payments**: The analysis suggests a low probability of tariffs being imposed on out-licensing deal payments, as US tariffs have primarily targeted tangible goods rather than service-related income [3][8]. 3. **Focus on Manufacturing Rights**: Most business development (BD) agreements grant manufacturing rights to licensors, with some companies like Pfizer planning to manufacture licensed products in the US [3][8]. 4. **Expectations for Future BD Deals**: There is an expectation for an increase in BD deals in the second half of 2025, particularly from key pharmaceutical companies with robust pipelines such as Hengrui, Hansoh, Sino Biopharma, and CSPC [4][8]. 5. **Minimal Impact of Tariffs**: Chinese pharmaceutical companies have low exposure to finished drug sales in the US, indicating that any potential tariffs would likely have a minimal immediate impact [4][8]. Additional Important Insights - **Market Reaction**: The Hang Seng Healthcare index experienced a 3% decline during the trading session, attributed to profit-taking and concerns over US pharmaceutical tariffs [8]. - **Service Trade Surplus**: The US maintains a services trade surplus with China, which may further reduce the likelihood of tariffs on service-related income, including intellectual property transfers [3][8]. - **Exhibit Data**: An exhibit presented data showing that most Chinese pharmaceutical companies have minimal overseas sales contributions, reinforcing the argument that tariffs would not significantly affect their operations [11][12]. Conclusion - The overall sentiment regarding the China Healthcare sector remains **attractive**, with expectations for continued growth in business development activities despite tariff concerns [5][67].

New Zealand Prime Minister Christopher Luxon has conceded the government is unlikely to win a reduction in the tariff rate the US has applied to New Zealand goods https://t.co/XCZs5CPwuh ...

Heard on the Street: Trump’s semiconductor-tariff regime appears unlikely to bring advanced chip-making roaring back in the U.S. https://t.co/I7bcRIiJ6v ...

MATT: BOLD IS GOING CRAZY 30 MINUTES UNTIL THE START OF TRADING. CASH GOLD IS GOING CRAZY. 30 MINUTES UNTIL THE START OF TRADING.KATIE: "BLOOMBERG OPEN INTEREST" STARTS RIGHT NOW. MATT: THE U.S. CONFIRMS ITS FOOTING LEVIES ON MARS. MEANWHILE, THE PRESIDENT POSSIBLE SURPRISE PICK FOR FED GOVERNOR GET SOME TIME TO FOCUS ON THE NEXT FED CHAIR AND ON THE CORPORATE FRONT, 10 STOCKS HAVE DRIVEN 80% OF THE S&P RALLY SINCE LIBERATION DAY.NO SURPRISE. KATIE: TAKING A LOOK AT META, THEY ANNOUNCED FINANCING FOR A $21 ...

Pricing Strategy & Tariff Impact - Lamborghini aims to maintain stable pricing for its Urus and other models [1] - The company acknowledges absorbing a portion of tariff costs on new cars [1] Global Trade & Market Access - Free trade is crucial for Lamborghini's global sales success [2] - "Made in Italy" is a key differentiator, limiting competition and emphasizing production location [2] Future Strategy & Investment - Lamborghini prioritizes profitability for reinvestment in future technologies [3] - The company focuses on brand awareness and image to cultivate a loyal customer base [3] - Staying ahead of trends is essential for Lamborghini's continued success [4]

Aircraft maker Pilatus Flugzeugwerke has stopped deliveries to the United States one day after the 39% tariff rate on Switzerland went into effect, as US President Trump’s surprise decision roils local manufacturers https://t.co/MabovsjNEr ...